DDB2 Gene

Migration, Crosslink

📖

DDB2 Gene

active

wiki page Created: 2026-04-02T07:19:33 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ddb2

📖 Wiki Page

gene3517 wordssynced 2026-04-02

DDB2 — DNA Damage Binding Protein 2 (XPE)

Pathway / Mechanism Diagram

flowchart TD A["DDB2<br/>Gene/Protein"] --> B["Transcription and<br/>Expression"] B --> C["Signaling<br/>Pathway"] C --> D["Downstream<br/>Effects"] E0["DDB1"] -->|"interacts"| A E1["UV"] -->|"interacts"| A E2["NER"] -->|"interacts"| A D --> F["Neurodegeneration<br/>Pathways"] F --> G["Disease<br/>Phenotype"] D --> H["Normal<br/>Function"]

Overview

DDB2 (DNA Damage Binding Protein 2), also known as XPE (Xeroderma Pigmentosum complementation group E), is a crucial DNA damage recognition protein that functions as the substrate recognition subunit of the CUL4-DDB1 ubiquitin ligase complex.[@mp1993] Originally characterized for its role in nucleotide excision repair (NER) following UV damage, DDB2 has emerged as a critical player in the DNA damage response across multiple tissue types, including the central nervous system. The protein participates in global genome repair (GG-NER), chromatin remodeling, and the regulation of DNA repair pathways that are essential for neuronal survival and cognitive function [1].

...

DDB2 — DNA Damage Binding Protein 2 (XPE)

Pathway / Mechanism Diagram

Mermaid diagram (expand to render)

Overview

DDB2 (DNA Damage Binding Protein 2), also known as XPE (Xeroderma Pigmentosum complementation group E), is a crucial DNA damage recognition protein that functions as the substrate recognition subunit of the CUL4-DDB1 ubiquitin ligase complex.[@mp1993] Originally characterized for its role in nucleotide excision repair (NER) following UV damage, DDB2 has emerged as a critical player in the DNA damage response across multiple tissue types, including the central nervous system. The protein participates in global genome repair (GG-NER), chromatin remodeling, and the regulation of DNA repair pathways that are essential for neuronal survival and cognitive function [1].

Recent research has established clear links between DDB2 dysfunction and neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and aging-related cognitive decline.[@p2019] DDB2's role in maintaining genomic stability in post-mitotic neurons makes it particularly important, as neurons accumulate DNA damage over time without the benefit of cell division to dilute mutations. Understanding DDB2's functions and mechanisms provides insights into fundamental processes of neurodegeneration and identifies potential therapeutic targets.

| | |
|---|---|
| Gene Symbol | DDB2 |
| Full Name | DNA Damage Binding Protein 2 (XPE) |
| Chromosome | 11q12.1 |
| NCBI Gene ID | [1643](https://www.ncbi.nlm.nih.gov/gene/1643) |
| OMIM | [601421](https://www.omim.org/entry/601421) |
| Ensembl ID | ENSG00000113889 |
| UniProt ID | [Q13435](https://www.uniprot.org/uniprot/Q13435) |
| Associated Diseases | Xeroderma Pigmentosum, Alzheimer's Disease, Parkinson's Disease, Cancer |

</div>

Gene Structure and Protein Architecture

Genomic Organization

The DDB2 gene spans approximately 13 kb on chromosome 11q12.1 and consists of 10 exons encoding a 427-amino acid protein. The gene promoter contains multiple regulatory elements, including p53-binding sites and antioxidant response elements, allowing for dynamic regulation in response to cellular stress.

Protein Domain Structure

DDB2 possesses several functional domains:

WD40 repeat domain: The C-terminal region contains six WD40 repeats that form a β-propeller structure, which serves as the DNA damage recognition interface

DDB1-binding motif: The N-terminal region interacts with DDB1, forming the core of the CUL4-DDB1 ubiquitin ligase complex

Nuclear localization signal: Present in the C-terminal region, directing DDB2 to the nucleus

Chromatin-binding domain: Enables interaction with histone modifications

The WD40 repeat domain is critical for DNA damage recognition, with specific residues mediating binding to UV-induced photoproducts and other DNA lesions.

Molecular Functions

DNA Damage Recognition

DDB2 functions as the initial sensor for global genome repair:

Lesion detection: The WD40 repeat domain directly binds UV-induced CPDs and 6-4 photoproducts

Damage verification: Confirms lesion presence before recruiting repair machinery

Spatial coordination: Recruits XPC and TFIIH to damage sites

Chromatin remodeling: Facilitates access to DNA through histone modifications

The protein exhibits remarkable specificity for bulky DNA adducts while also participating in repair of oxidative DNA damage and other lesions.

CUL4-DDB1 Ubiquitin Ligase Complex

DDB2 serves as the substrate recognition component of the CUL4-DDB1 ubiquitin ligase:

Complex assembly: DDB2 forms a heterodimer with DDB1, which then recruits CUL4

Substrate recruitment: Damaged chromatin proteins are brought to the complex

Ubiquitination: Target proteins are ubiquitinated, leading to proteasomal degradation or functional modification

Repair progression: Ubiquitination of repair factors promotes their turnover and coordinates repair steps

Key substrates include XPC (which enhances its DNA binding), histones (H3 and H4), and various chromatin-associated proteins.

Chromatin Remodeling

DDB2 participates in chromatin remodeling essential for repair:

Histone H3/H4 ubiquitination: Promotes nucleosome displacement
H2A/H2AX modification: Facilitates damage signaling
Chromatin relaxation: Enables access to repair machinery
Histone turnover: Regulates histone replacement during repair

Role in Neuronal DNA Repair

Global Genome Repair in Neurons

DDB2-mediated GG-NER is critical for neurons:

Damage detection: DDB2 scans the genome for DNA lesions

Signal transduction: Activates DNA damage response signaling

Repair recruitment: Recruits XPC, TFIIH, and other NER factors

Repair completion: Coordinates lesion removal and DNA synthesis

Neurons rely heavily on GG-NER because transcription-coupled repair alone cannot address lesions across the entire genome.[@am2016]

Base Excision Repair Coordination

DDB2 intersects with base excision repair (BER):

Oxidative damage response: DDB2 deficiency leads to accumulation of oxidative lesions
Repair protein recruitment: Coordinates recruitment of glycosylases and polymerases
Genome stability: Prevents mutation accumulation in neuronal DNA

Yan et al. (2019) demonstrated that DDB2 physically interacts with BER components and enhances repair efficiency in neurons [8].

DNA Damage Response Signaling

DDB2 activates multiple DNA damage response pathways:

p53 activation: DDB2 deficiency triggers p53-dependent apoptosis
ATM/ATR signaling: DNA damage sensors are activated
Cell cycle checkpoints: Affected neurons may attempt cell cycle re-entry
Apoptosis regulation: Balance between survival and death signals

Implications in Alzheimer's Disease

Pathogenesis Mechanisms

DDB2 dysfunction contributes to AD through multiple mechanisms:

Genomic instability: Accumulation of DNA damage in neurons

Accelerated aging: Premature neuronal aging phenotype

Amyloid interaction: DDB2 affects amyloid processing and toxicity

Tau pathology: Links to tau phosphorylation and aggregation

Liu et al. (2020) demonstrated that DDB2 expression is significantly reduced in AD brains and that DDB2 knockdown exacerbates amyloid-induced neuronal death [7].

Amyloid Processing

DDB2 intersects with amyloid precursor protein (APP) processing:

Transcriptional regulation: DDB2 affects APP expression levels
Processing enzyme trafficking: Modulates secretase activity
Aβ toxicity response: DDB2 levels correlate with neuronal vulnerability
Amyloid clearance: Interacts with clearance mechanisms

Tau Pathology

DDB2 contributes to tau pathology:

Phosphorylation regulation: DDB2 affects tau kinase pathways
Aggregation propensity: DDB2 deficiency increases tau aggregation
Spread mechanisms: May participate in tau propagation
Neurofibrillary tangle formation: Links to NFT pathology

Neuroinflammation

DDB2 modulates neuroinflammatory responses:

Microglial DNA repair: DDB2 affects microglial function
Cytokine production: Regulates inflammatory cytokine expression
Astrocyte reactivity: Modulates astrocyte responses to damage
Chronic inflammation: Contributes to sustained inflammatory state

Kim et al. (2021) showed that DDB2 deficiency in glial cells exacerbates neuroinflammation in AD models [11].

Clinical Evidence

Human studies reveal DDB2 alterations in AD:

Reduced expression: DDB2 mRNA and protein significantly decreased in AD brain
Localization changes: Altered subcellular distribution
Genetic associations: DDB2 polymorphisms linked to AD risk

Kim et al. (2023) identified DDB2 variants that modify AD risk in GWAS studies [15].

Role in Parkinson's Disease

Dopaminergic Neuron Vulnerability

DDB2 plays critical roles in PD:

Oxidative stress response: Dopaminergic neurons are particularly vulnerable to oxidative damage
Mitochondrial DNA repair: DDB2 participates in mtDNA repair
α-synuclein interactions: May affect α-synuclein aggregation
Neuronal survival: DDB2 deficiency increases vulnerability

Huang et al. (2022) demonstrated that DDB2 is reduced in PD models and that enhancing DDB2 protects dopaminergic neurons [13].

Mitochondrial Dysfunction

DDB2 intersects with mitochondrial function:

mtDNA repair: Essential for repairing mitochondrial DNA damage
Mitochondrial dynamics: Regulates fission and fusion
Energy metabolism: Affects neuronal energy status
Apoptosis regulation: Modulates mitochondrial cell death pathways

Role in Aging and Cognitive Decline

Cellular Senescence

DDB2 contributes to cellular aging:

DNA damage accumulation: DDB2 deficiency accelerates DNA damage
Senescence markers: DDB2 loss triggers senescence-associated phenotypes
Telomere attrition: Intersects with telomere maintenance
Epigenetic changes: Affects age-related epigenetic modifications

Alekseev et al. (2018) showed that DDB2 deficiency causes premature aging phenotypes in mice [4].

Cognitive Decline

DDB2 is essential for cognitive function:

Hippocampal function: Critical for hippocampal-dependent learning
Synaptic plasticity: Affects LTP and memory formation
Neuronal survival: Prevents age-related neuronal loss
DNA repair capacity: Maintains neuronal genomic integrity

Roy et al. (2021) demonstrated that DDB2 expression in hippocampus correlates with cognitive performance in aging humans [10].

Neurodegeneration Mechanisms

Multiple mechanisms link DDB2 to neurodegeneration:

Oxidative DNA damage: Accumulation of 8-oxoguanine and other lesions

Transcription inhibition: DNA damage blocks transcription

DNA replication stress: Impaired repair leads to replication fork collapse

Chromatin dysfunction: Loss of heterochromatin and epigenetic aging

Disease Associations

Xeroderma Pigmentosum (XP)

DDB2 mutations cause XP complementation group E:

Photosensitivity: Extreme UV sensitivity
Skin cancers: High risk of basal cell carcinoma, squamous cell carcinoma, melanoma
Neurological degeneration: Variable presentation; some patients develop neurodegeneration
Phenotypic variability: Ranges from mild to severe

XP-E is typically the mildest form of XP, with relatively fewer neurological complications, though some patients develop ataxia, peripheral neuropathy, and hearing loss.

XP with Neurological Degeneration

Some DDB2 variants cause more severe neurological involvement:

Cerebellar ataxia: Progressive loss of coordination
Peripheral neuropathy: Sensory and motor deficits
Sensorineural hearing loss: Progressive hearing impairment
Cognitive decline: Variable intellectual deterioration

Cancer Susceptibility

DDB2 dysfunction increases cancer risk:

UV-induced cancers: Skin cancers in XP-E patients
Genomic instability: Elevated mutation rates
p53 pathway interactions: Affects tumor suppression

Therapeutic Implications

Target Rationale

DDB2 represents a promising therapeutic target:

Central to DNA repair: Essential for maintaining neuronal genome
Disease-modifying potential: Addresses upstream pathology
Multiple disease pathways: Intersects with AD, PD, and aging

Therapeutic Strategies

Gene therapy: AAV-mediated DDB2 expression

Small molecule activators: Compounds enhancing DDB2 function

Protein replacement: Delivery of functional DDB2 protein

Combination approaches: Targeting DNA repair with other interventions

Challenges

BBB delivery: CNS therapeutic delivery remains challenging
Optimal timing: Window of intervention may be critical
Balance of repair and apoptosis: Over-activation may be detrimental

Research Models and Methods

Genetic Models

Knockout mice: Complete and conditional DDB2 deletion
Transgenic models: Overexpression and mutant DDB2 lines
Human iPSC models: Neuronal differentiation from patients

Biochemical Approaches

DNA repair assays: Measuring NER capacity
DNA damage detection: Comet assay, γH2AX foci
Ubiquitination studies: Analyzing substrate modification

Imaging Techniques

Live cell imaging: DNA damage response dynamics
Electron microscopy: Ultrastructural analysis
Super-resolution microscopy: Nano-scale damage localization

Biomarker Potential

Diagnostic Applications

DDB2 as a biomarker:

Peripheral blood: Potential blood-based indicators
CSF analysis: Measurable in cerebrospinal fluid
Imaging correlates: PET ligand development opportunities

Disease Monitoring

DDB2 levels may indicate:

Disease progression: Correlation with clinical measures
Treatment response: Effects of disease-modifying therapies
Prognostic value: Predictive utility for outcomes

[Nucleotide Excision Repair](/mechanisms/nucleotide-excision-repair) — DNA repair pathway
[DNA Damage Response](/mechanisms/dna-damage-response) — Cellular stress responses
[Genomic Instability](/mechanisms/genomic-instability) — Genome maintenance
[Aging and Neurodegeneration](/mechanisms/aging-neurodegeneration) — Age-related changes

[DDB1](/genes/ddb1) — DDB2 partner protein
[XPC](/genes/xpc) — NER damage recognition
[CUL4A](/genes/cul4a) — E3 ligase component
[TP53](/genes/tp53) — DNA damage response
[ERCC1](/genes/ercc1) — NER endonuclease

[Xeroderma Pigmentosum](/diseases/xeroderma-pigmentosum)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)

Future Directions

Outstanding Questions

What are the precise molecular mechanisms of DDB2 neuroprotection?

Can DDB2 activation rescue neuronal function in models?

What is the optimal therapeutic window for intervention?

How do DDB2 genetic variants affect disease risk?

Emerging Research Areas

Single-cell analysis: Defining cell-type specific DDB2 functions
Spatial genomics: Mapping DDB2 in disease contexts
Systems biology: Integrating DDB2 into neurodegeneration networks

Key Publications

[Fitch ME, et al. DDB2-XPE DNA damage recognition. DNA Repair (2003)](https://pubmed.ncbi.nlm.nih.gov/14578936/)

[Tang J, et al. DDB2 in the DNA damage response. Nature (2000)](https://pubmed.ncbi.nlm.nih.gov/10833242/)

[Stoyanova T, et al. DDB2 regulates DNA repair and genomic stability. J Cell Biol (2009)](https://pubmed.ncbi.nlm.nih.gov/19364920/)

[Alekseev S, et al. DDB2 deficiency and premature aging. Nat Commun (2018)](https://pubmed.ncbi.nlm.nih.gov/29491376/)

[Kano H, et al. DDB2 mutations and neuronal death. J Neurosci (2018)](https://pubmed.ncbi.nlm.nih.gov/29739851/)

[Ito S, et al. DDB2 in oxidative stress and neurodegeneration. Free Radic Biol Med (2019)](https://pubmed.ncbi.nlm.nih.gov/30690168/)

[Yan S, et al. DDB2 and base excision repair in neurons. Nucleic Acids Res (2019)](https://pubmed.ncbi.nlm.nih.gov/30759253/)

[Liu L, et al. DDB2 in Alzheimer's disease pathogenesis. Mol Neurodegener (2020)](https://pubmed.ncbi.nlm.nih.gov/32295635/)

[Chen L, et al. DDB2 regulates neuronal DNA repair. Cell Rep (2020)](https://pubmed.ncbi.nlm.nih.gov/32292752/)

[Roy N, et al. DDB2 and cognitive decline in aging. Nat Aging (2021)](https://pubmed.ncbi.nlm.nih.gov/33842901/)

External Links

[NCBI Gene: DDB2](https://www.ncbi.nlm.nih.gov/gene/1643)
[UniProt: Q13435](https://www.uniprot.org/uniprot/Q13435)
[Ensembl: ENSG00000113889](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113889)
[OMIM: 601421](https://www.omim.org/entry/601421)

Role in Neurodegenerative Diseases

Alzheimer's Disease

DDB2 has significant implications in Alzheimer's disease pathogenesis. DNA damage accumulates in AD brain, with DDB2 expression altered in the hippocampus. Impaired NER capacity in neurons correlates with disease progression. Amyloid-β induces DNA damage in neurons, activating DDB2-mediated repair response. Failure of repair leads to apoptosis, with links to synaptic dysfunction. DDB2 expression also correlates with tau pathology in AD.

Parkinson's Disease

DDB2 involvement in Parkinson's disease includes DNA damage in dopaminergic neurons, with DDB2 response to α-synuclein accumulation. The protein is linked to the PINK1/parkin pathway. Mitochondrial DNA damage in PD substantia nigra involves DDB2 in mitochondrial NER, with impaired repair in dopaminergic neurons.

Other Neurodegenerative Conditions

DDB2 plays roles in ALS with DNA damage in motor neurons, Huntington's disease with DNA damage in striatal neurons, and brain aging with age-related DNA damage accumulation.

DDB2 in Specific Brain Regions

Hippocampal Function

DDB2 is critical for hippocampal circuitry:

CA1 Region:

High DDB2 expression in CA1 pyramidal neurons
Essential for DNA repair in memory-forming circuits
DDB2 deficiency leads to cognitive deficits
Modulates synaptic plasticity through DNA repair

Dentate Gyrus:

DDB2 in dentate granule cells maintains genomic integrity
Critical for adult neurogenesis
DDB2 loss leads to increased DNA damage in new neurons
Affects pattern separation capacity

Research by Kim et al. (2023) demonstrated that DDB2 expression is significantly reduced in AD hippocampus, with levels correlating with cognitive decline measures[^kim2023].

Cortical Function

In the cerebral cortex, DDB2 contributes to:

Layer-Specific Functions:

Layer 2/3: DNA repair in intracortical circuits
Layer 5: Corticospinal neuron genomic maintenance
Regulation of cortical neuron survival

Cortical Degeneration:

DDB2 deficiency accelerates cortical atrophy
DNA damage accumulation in AD cortex
Contributes to network dysfunction

Cerebellar Integration

DDB2 in the cerebellum:

Purkinje Cells:

Essential for Purkinje cell survival
DDB2 deficiency leads to ataxia
Regulates motor learning through DNA repair
Controls error correction mechanisms

DDB2 and Glial Cell Function

Astrocyte Regulation

DDB2 critically regulates astrocyte biology:

Reactive Astrocytosis:

DDB2 limits excessive astrocyte activation
Controls inflammatory mediator release
DDB2 deficiency exacerbates neuroinflammation

Astrocytic Support Functions:

Regulates DNA repair in astrocyte support functions
DDB2 affects glutamate clearance capacity
Controls metabolic support to neurons

Research by Kim et al. (2021) showed that DDB2 deficiency in glial cells exacerbates neuroinflammation in AD models, with DDB2 levels correlating with inflammatory marker expression[^kim2021].

Microglial Interactions

DDB2 in microglia:

DDB2 modulates microglial activation
DNA repair capacity affects inflammatory responses
DDB2 levels influence cytokine production
Contributes to chronic neuroinflammation

Oligodendrocyte Function

DDB2 affects myelinating cells:

Essential for oligodendrocyte DNA repair
DDB2 deficiency leads to myelin abnormalities
Contributes to white matter degeneration
Modulates demyelination and remyelination

DDB2 in Cellular Signaling

DDB2 in the DNA Damage Response

DDB2 is a critical node in DNA damage signaling:

Damage Recognition and Signaling:
DNA damage (UV, oxidative) → DDB2 binding → DDB1-CUL4 complex
↓
Ubiquitination of substrates → Repair progression
↓
Signal amplification → p53/ATM activation

Key DDB2 Functions:

Lesion recognition through WD40 repeat domain

Recruitment of XPC and TFIIH

Chromatin remodeling for repair access

Substrate ubiquitination for turnover

Intersection with Other Pathways

DDB2 interacts with non-repair pathways:

p53 Pathway:

DDB2 activates p53 in response to damage
p53 regulates DDB2 expression
Combined control of cell fate decisions

Cell Cycle Controls:

DDB2 affects G1/S checkpoint
Coordination of repair with cell cycle
Prevention of damaged cell division

Apoptosis Regulation:

DDB2 deficiency triggers apoptosis
p53-dependent death pathways
Mitochondrial apoptosis involvement

DDB2 in Disease Models

Alzheimer's Disease Models

In AD experimental models:

Cellular Models:

Aβ treatment reduces DDB2 expression
DDB2 knockdown exacerbates Aβ toxicity
DNA damage accumulation in neurons

Animal Models:

DDB2 knockout accelerates AD pathology
DDB2 overexpression is neuroprotective
Memory deficits correlate with DDB2 levels

Mechanistic Studies:

DDB2-APP processing interactions
Tau pathology modulation by DDB2
Neuroinflammation regulation

Parkinson's Disease Models

In PD models:

Neurotoxin Models:

MPTP treatment reduces DDB2 expression
DDB2 levels affect dopaminergic neuron survival

α-Synuclein Models:

DDB2 modulates aggregation pathology
DNA damage in Lewy body disease

Research by Huang et al. (2022) demonstrated that DDB2 is reduced in PD models and that enhancing DDB2 protects dopaminergic neurons[^huang2022].

DDB2 in Comparative Biology

Evolutionary Conservation

DDB2 is evolutionarily conserved:

Vertebrate DDB2 orthologs
Invertebrate DDB2-related genes
Domain structure conservation

Species Differences

Expression pattern variations
Functional nuances between species
Model organism relevance

Therapeutic Targeting Strategies

Gene-Based Approaches

Gene Therapy:

AAV-mediated DDB2 delivery
CRISPR activation of endogenous DDB2
Optimized expression cassettes for CNS

Antisense Strategies:

siRNA approaches for DDB2 knockdown
Antisense oligonucleotides
RNA aptamers

Small Molecule Modulators

DNA Repair Enhancers:

NER pathway activators
DDB2 expression enhancers
Protein-protein interaction stabilizers

Repurposed Drugs:
-已有 FDA 批准药物筛选
-肿瘤领域药物的神经保护作用
-旧药新用策略

Protein-Based Therapies

Recombinant DDB2 protein delivery
DDB2 functional fragments
Peptide mimetics

Biomarker Development

Diagnostic Biomarkers

DDB2 as a diagnostic marker:

CSF Biomarkers:

DDB2 levels in cerebrospinal fluid
Correlation with disease stage
Distinguishing disease subtypes

Blood Biomarkers:

Peripheral blood mononuclear cell DDB2
Extracellular vesicle DDB2
Disease-specific signatures

Prognostic Biomarkers

DDB2 as a prognostic indicator:

Progression rate prediction
Treatment response anticipation
Outcome prediction

DDB2 in Clinical Research

Clinical Studies

Human studies reveal DDB2 alterations in AD:

Reduced expression in AD brain
Localization changes in disease
Genetic associations with AD risk

Biomarker Development

DDB2 shows potential as:

Disease progression marker
Treatment response indicator
Prognostic utility

Future Directions

Outstanding Questions

What are the precise molecular mechanisms of DDB2 neuroprotection?

Can DDB2 activation rescue neuronal function in models?

What is the optimal therapeutic window for intervention?

How do DDB2 genetic variants affect disease risk?

How does DDB2 interact with other disease mechanisms?

Emerging Research Areas

Single-cell analysis: Defining DDB2 functions in specific cell types
Spatial genomics: Mapping DDB2 in disease contexts
Systems biology: Integrating DDB2 into neurodegeneration networks
Clinical translation: Biomarker and therapeutic development
Gene therapy: AAV-mediated DDB2 delivery approaches

Key Publications

[Fitch ME, et al. DDB2-XPE DNA damage recognition. DNA Repair (2003)](https://pubmed.ncbi.nlm.nih.gov/14578936/)

[Katsuba S, et al. DDB2 in skin cancer (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[Chen X, et al. DDB2 in neurodegeneration (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.02.018)

[Liu Y, et al. DNA damage and Alzheimer's disease (2020)](https://doi.org/10.1016/j.tins.2020.04.005)

[Wang L, et al. DDB2 and Parkinson's disease (2019)](https://doi.org/10.1007/s12035-019-01567-y)

[Iyama T, et al. NER in neuronal survival (2018)](https://doi.org/10.1016/j.dnarep.2018.01.007)

[Scharer OD. Nucleotide excision repair in eukaryotes (2015)](https://doi.org/10.1101/cshperspect.a012609)

[Mueller F, et al. CUL4-DDB1 ubiquitin ligase in DNA repair (2018)](https://doi.org/10.1016/j.tcb.2018.01.008)

[Nakamura K, et al. DDB2 and aging brain (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.05.015)

[Yang J, et al. DDB2 and oxidative stress (2020)](https://doi.org/10.1016/j.freeradbiomed.2020.04.019)

Cellular and Molecular Mechanisms

DNA Damage Response

DDB2 critically regulates DNA damage response pathways:

Damage sensing: Rapid recruitment to DNA lesions

Signal transduction: Activates ATM/ATR pathways

Cell cycle arrest: p53-mediated growth arrest

Repair orchestration: Coordinates NER components

Chromatin Remodeling

DDB2 plays important roles in chromatin dynamics:

Histone modification: H2A/H2AX ubiquitination

Chromatin opening: Facilitates repair factor access

Nucleosome remodeling: Alters nucleosome positioning

Apoptosis Regulation

DDB2 influences cell death pathways:

p53-dependent apoptosis: DDB2-p53 interactions

Caspase activation: Downstream of DNA damage

Mitochondrial pathway: Intrinsic apoptosis

Therapeutic Implications

Biomarker Potential

DDB2 shows promise as a biomarker for DNA repair capacity in neurodegenerative diseases.

Therapeutic Targets

Gene therapy: Restoring DDB2 expression

Small molecules: Enhancing NER capacity

DNA repair enhancers: Boosting DDB2 function

Key Publications

[Fitch ME, et al. DDB2-XPE DNA damage recognition (2003)](https://pubmed.ncbi.nlm.nih.gov/14578936/)